Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker BDSX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Jack W. Schuler 10% owner | BDSX Biodesix, Inc. | Buy | 100,000 | $10.02 | $1.0M Buy | Form 4 ↗ |
| Aug 12, 2026 | Jack W. Schuler 10% owner | BDSX Biodesix, Inc. | Buy | 15,000 | $24.47 | $367.1K Buy | Form 4 ↗ |
| Aug 11, 2026 | Jack W. Schuler 10% owner | BDSX Biodesix, Inc. | Buy | 13,700 | $24.01 | $328.9K Buy | Form 4 ↗ |
| Aug 10, 2026 | Jack W. Schuler 10% owner | BDSX Biodesix, Inc. | Buy | 13,900 | $24.25 | $337.1K Buy | Form 4 ↗ |
| Feb 23, 2026 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 211 | $12.78 | $2,697 Sale | Form 4 ↗ |
| Feb 23, 2026 | Robin Harper Cowie CFO, Sec'y & Treasurer | BDSX Biodesix, Inc. | Sale | 535 | $12.78 | $6,837 Sale | Form 4 ↗ |
| Feb 23, 2026 | Scott Hutton President & CEO, Director | BDSX Biodesix, Inc. | Sale | 1,490 | $12.78 | $19.0K Sale | Form 4 ↗ |
| Feb 23, 2026 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 556 | $12.78 | $7,106 Sale | Form 4 ↗ |
| Feb 23, 2026 | Kieran O'Kane Chief Commercial Officer | BDSX Biodesix, Inc. | Sale | 535 | $12.78 | $6,837 Sale | Form 4 ↗ |
| Feb 10, 2026 | Robin Harper Cowie CFO, Sec'y & Treasurer | BDSX Biodesix, Inc. | Sale | 941 | $10.08 | $9,485 Sale | Form 4 ↗ |
| Feb 10, 2026 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 101 | $10.08 | $1,018 Sale | Form 4 ↗ |
| Feb 10, 2026 | Kieran O'Kane Chief Commercial Officer | BDSX Biodesix, Inc. | Sale | 584 | $10.08 | $5,887 Sale | Form 4 ↗ |
| Feb 10, 2026 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 540 | $10.08 | $5,443 Sale | Form 4 ↗ |
| Feb 10, 2026 | Scott Hutton President & CEO, Director | BDSX Biodesix, Inc. | Sale | 3,559 | $10.08 | $35.9K Sale | Form 4 ↗ |
| Jan 26, 2026 | Jack W. Schuler 10% owner | BDSX Biodesix, Inc. | Buy | 20,000 | $11.80 | $236.0K Buy | Form 4 ↗ |
| Jan 23, 2026 | Jack W. Schuler 10% owner | BDSX Biodesix, Inc. | Buy | 80,000 | $11.81 | $944.8K Buy | Form 4 ↗ |
| Jan 22, 2026 | Jack W. Schuler 10% owner | BDSX Biodesix, Inc. | Buy | 82,465 | $10.96 | $903.8K Buy | Form 4 ↗ |
| Jan 16, 2026 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 83 | $8.15 | $676 Sale | Form 4 ↗ |
| Jan 16, 2026 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 298 | $8.15 | $2,429 Sale | Form 4 ↗ |
| Jan 16, 2026 | Kieran O'Kane Chief Commercial Officer | BDSX Biodesix, Inc. | Sale | 298 | $8.15 | $2,429 Sale | Form 4 ↗ |
| Jan 16, 2026 | Scott Hutton President & CEO, Director | BDSX Biodesix, Inc. | Sale | 970 | $8.15 | $7,906 Sale | Form 4 ↗ |
| Jan 16, 2026 | Robin Harper Cowie CFO, Sec'y & Treasurer | BDSX Biodesix, Inc. | Sale | 298 | $8.15 | $2,429 Sale | Form 4 ↗ |
| Nov 10, 2025 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 13 | $7.62 | $99.06 Sale | Form 4 ↗ |
| Nov 10, 2025 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 23 | $7.62 | $175 Sale | Form 4 ↗ |
| Nov 10, 2025 | Kieran O'Kane Chief Commercial Officer | BDSX Biodesix, Inc. | Sale | 25 | $7.62 | $191 Sale | Form 4 ↗ |
| Nov 10, 2025 | Scott Hutton President & CEO, Director | BDSX Biodesix, Inc. | Sale | 189 | $7.62 | $1,440 Sale | Form 4 ↗ |
| Nov 10, 2025 | Robin Harper Cowie CFO, Sec'y & Treasurer | BDSX Biodesix, Inc. | Sale | 50 | $7.62 | $381 Sale | Form 4 ↗ |
| Sep 19, 2025 | Jack W. Schuler Director, 10% owner | BDSX Biodesix, Inc. | Buy | 142,045 | $7.04 | $1000.0K Buy | Form 4 ↗ |
| Sep 18, 2025 | Jack W. Schuler Director, 10% owner | BDSX Biodesix, Inc. | Buy | 3,056 | $6.17 | $18.9K Buy | Form 4 ↗ |
| Sep 17, 2025 | Jack W. Schuler Director, 10% owner | BDSX Biodesix, Inc. | Buy | 15,317 | $6.04 | $92.5K Buy | Form 4 ↗ |
| Aug 29, 2025 | Jack W. Schuler Director, 10% owner | BDSX Biodesix, Inc. | Buy | 3.49M | $0.43 | $1.5M Buy | Form 4 ↗ |
| Aug 13, 2025 | Robin Harper Cowie CFO, Sec'y & Treasurer | BDSX Biodesix, Inc. | Sale | 988 | $0.42 | $415 Sale | Form 4 ↗ |
| Aug 13, 2025 | Scott Hutton President & CEO, Director | BDSX Biodesix, Inc. | Sale | 3,772 | $0.42 | $1,584 Sale | Form 4 ↗ |
| Aug 13, 2025 | Kieran O'Kane Chief Commercial Officer | BDSX Biodesix, Inc. | Sale | 476 | $0.42 | $200 Sale | Form 4 ↗ |
| Aug 13, 2025 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 442 | $0.42 | $186 Sale | Form 4 ↗ |
| Aug 13, 2025 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 228 | $0.42 | $95.76 Sale | Form 4 ↗ |
| May 19, 2025 | Jack W. Schuler Director, 10% owner | BDSX Biodesix, Inc. | Buy | 723,239 | $0.34 | $245.9K Buy | Form 4 ↗ |
| May 16, 2025 | Jack W. Schuler Director, 10% owner | BDSX Biodesix, Inc. | Buy | 4.00M | $0.27 | $1.1M Buy | Form 4 ↗ |
| May 13, 2025 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 112 | $0.35 | $39.2 Sale | Form 4 ↗ |
| May 13, 2025 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 222 | $0.35 | $77.7 Sale | Form 4 ↗ |
| May 13, 2025 | Kieran O'Kane Chief Commercial Officer | BDSX Biodesix, Inc. | Sale | 238 | $0.35 | $83.3 Sale | Form 4 ↗ |
| May 13, 2025 | Scott Hutton President & CEO, Director | BDSX Biodesix, Inc. | Sale | 1,887 | $0.35 | $660 Sale | Form 4 ↗ |
| May 13, 2025 | Robin Harper Cowie CFO, Sec'y & Treasurer | BDSX Biodesix, Inc. | Sale | 496 | $0.35 | $174 Sale | Form 4 ↗ |
| May 12, 2025 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 112 | $0.36 | $40.32 Sale | Form 4 ↗ |
| May 12, 2025 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 223 | $0.36 | $80.28 Sale | Form 4 ↗ |
| May 12, 2025 | Kieran O'Kane Chief Commercial Officer | BDSX Biodesix, Inc. | Sale | 239 | $0.36 | $86.04 Sale | Form 4 ↗ |
| May 12, 2025 | Scott Hutton President & CEO, Director | BDSX Biodesix, Inc. | Sale | 1,888 | $0.36 | $680 Sale | Form 4 ↗ |
| May 12, 2025 | Robin Harper Cowie CFO, Sec'y & Treasurer | BDSX Biodesix, Inc. | Sale | 496 | $0.36 | $179 Sale | Form 4 ↗ |
| Feb 11, 2025 | Chris Vazquez Chief Accounting Officer | BDSX Biodesix, Inc. | Sale | 3,630 | $0.92 | $3,340 Sale | Form 4 ↗ |
| Feb 11, 2025 | Gary Anthony Pestano Chief Development Officer | BDSX Biodesix, Inc. | Sale | 16,748 | $0.92 | $15.4K Sale | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:03 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances